These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6139097)

  • 21. Psychopharmacological profile of dapiprazole, a new potential antipsychotic agent.
    Silvestrini B; Lisciani R; Baldini A; de Sanctis AJ
    Arzneimittelforschung; 1982; 32(6):668-73. PubMed ID: 6126197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGYT-2509 a novel neuroleptic agent without extrapyramidal and endocrine side effects.
    Gacsályi I; Petöcz L; Fekete MI; Bükkfálvi B; Görgenyi F; Arató M
    Pol J Pharmacol Pharm; 1988; 40(6):613-9. PubMed ID: 2908364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological evaluation of clomacran, a new potent psychotropic agent.
    Fowler PJ; Zirkle CL; Macko E; Kaiser C; Sarau H; Tedeschi DH
    Arzneimittelforschung; 1977; 27(4):866-72. PubMed ID: 17419
    [No Abstract]   [Full Text] [Related]  

  • 24. [A neuropharmacological study of isoteolin (IST)].
    Markov M; Zheliazkov D
    Eksp Med Morfol; 1990; 29(3):33-8. PubMed ID: 2276375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
    J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substituted ergolines: potential antipsychotics with unique profile. I. Psychopharmacological characterization.
    Groó D; Palosi A
    Pol J Pharmacol Pharm; 1988; 40(6):593-601. PubMed ID: 2908363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G; Rogóz Z; Wieczorek A
    Pol J Pharmacol; 1997; 49(1):5-15. PubMed ID: 9431546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of the pharmacological activity of N-(4-picolyl)-3,5-dimethylbenzamide (M-14012-4) and its N-oxide metabolite (M-3312-4). New pharmacological aspects].
    Casais L; Colom A; Martín del Río MP; Vallejo M; Cuenca E
    Arch Farmacol Toxicol; 1979 Dec; 5(3):159-64. PubMed ID: 44673
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of suloctidil on the central and peripheral nervous systems].
    Nishi H; Watanabe T; Mori M
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):191-212. PubMed ID: 6319248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.
    Chipkin RE; Iorio LC; Coffin VL; McQuade RD; Berger JG; Barnett A
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1093-102. PubMed ID: 2905002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Classification of neuroleptics--zotepine.
    Puech AJ; Martin P
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):1-3. PubMed ID: 2883676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroleptic-like activity of the tripeptide neurotensin analog GZR-123].
    Guzevatykh LS; Ostrovskaia RU; Gudasheva TA; Zaĭtseva NI; Voronina TA
    Eksp Klin Farmakol; 2002; 65(1):3-6. PubMed ID: 12025780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
    Corral C; Lissavetzky J; Valdeolmillos A; Bravo L; Darias V; Sánchez Mateo C
    Arzneimittelforschung; 1992 Jul; 42(7):896-900. PubMed ID: 1358080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and pharmacological properties of new derivatives of 1-diphenylacetamide-2-butanol.
    Kolasa K; Kleinrok Z; Pietrasiewicz T; Czechowska G; Zejc A; Gajewczyk L
    Pol J Pharmacol Pharm; 1989; 41(5):475-81. PubMed ID: 2577062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromoperidol, a new potent neuroleptic of the butyrophenone series. Comparative pharmacology of bromoperidol and haloperidol.
    Niemegeers CJ; Janssen PA
    Arzneimittelforschung; 1974 Jan; 24(1):45-52. PubMed ID: 4406109
    [No Abstract]   [Full Text] [Related]  

  • 36. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
    Voith K; Herr F
    Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological actions of SM-9018, a new neuroleptic drug with both potent 5-hydroxytryptamine2 and dopamine2 antagonistic actions.
    Hirose A; Kato T; Ohno Y; Shimizu H; Tanaka H; Nakamura M; Katsube J
    Jpn J Pharmacol; 1990 Jul; 53(3):321-9. PubMed ID: 1975278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Norzotepine, a major metabolite of zotepine, exerts atypical antipsychotic-like and antidepressant-like actions through its potent inhibition of norepinephrine reuptake.
    Shobo M; Kondo Y; Yamada H; Mihara T; Yamamoto N; Katsuoka M; Harada K; Ni K; Matsuoka N
    J Pharmacol Exp Ther; 2010 Jun; 333(3):772-81. PubMed ID: 20223878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental evaluation of the possible neuroleptic activity of clomipramine.
    Balsara JJ; Chandorkar AG
    Indian J Physiol Pharmacol; 1978; 22(3):263-9. PubMed ID: 31334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.